Kyverna Therapeutics (KYTX) Stock Price
$2.78 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Kyverna Therapeutics, AI stock picks, stock alerts and much more.
KYTX AI Stock Analysis
AI stock analysis for KYTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Kyverna Therapeutics (KYTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Kyverna Therapeutics (KYTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Kyverna Therapeutics (KYTX), currently trading at $2.78, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About KYTX
-
Kyverna Therapeutics, Inc.
-
Symbol
KYTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
120M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
KYTX Alternative Data
Web Traffic
Kyverna Therapeutics receives an estimated 6375 monthly visitors to kyvernatx.com.
-
Web Traffic
6375
-
Change from Previous Month
7.5%
-
3 Month Change
9.4%
News Mentions
Kyverna Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
50%
-
3 Month Change
0%
Reddit Mentions
Kyverna Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Kyverna Therapeutics has 240 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.6% over the last month.
-
Twitter Followers
240
-
Daily Change
0%
-
1 Month Change
2.6%
-
3 Month Change
36.8%
LinkedIn Followers
20,963 are following Kyverna Therapeutics on LinkedIn, up by 7.2% over the last month.
-
LinkedIn Followers
20963
-
Daily Change
0.2%
-
1 Month Change
7.2%
-
3 Month Change
18.5%
Job Postings
Kyverna Therapeutics currenly has an estimated 13 open job postings, up by 44.4% over the last month.
-
Job Postings
13
-
Daily Change
7.1%
-
1 Month Change
44.4%
-
3 Month Change
45.8%
LinkedIn Employees
According to LinkedIn, Kyverna Therapeutics has 137 employees, down by -2.1% over the last month.
-
LinkedIn Employees
137
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
0.7%
Business Outlook
-
Business Outlook
19
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
KYTX Financials
KYTX Key Metrics
-
Total Revenue
$0
-
Net Income
-$34.5M
-
Earnings per Share
-$0.8
-
Free cash flow
-$27.6M
-
EBITDA
-$33.9M
-
EBITDA Ratio
0
-
Total Assets
$339.2M
KYTX 2-year Revenue & Income
KYTX 2-year Free Cash Flow
KYTX Technicals
KYTX SMA
KYTX RSI
FAQ
What's the current price of Kyverna Therapeutics (KYTX) Stock?
The price of an Kyverna Therapeutics (KYTX) share is $2.78.
What's the market cap of Kyverna Therapeutics?
The current market cap of Kyverna Therapeutics is 120M.
Should I buy or sell KYTX?
Kyverna Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Kyverna Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Kyverna Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Kyverna Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Kyverna Therapeutics (KYTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Kyverna Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Kyverna Therapeutics (KYTX) that investors often compare it to?
Kyverna Therapeutics (KYTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Kyverna Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Kyverna Therapeutics' stock price to be around $2.57 in 2026. Starting from the current price of $2.78, this represents a 7.7% change in price, indicating a bearish outlook for the stock.
How to buy Kyverna Therapeutics (KYTX) Stock?
Kyverna Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Kyverna Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.